Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Precision Biosciences (DTIL) over the last 7 years, with Q3 2025 value amounting to 0.01.

  • Precision Biosciences' Asset Utilization Ratio fell 9853.51% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 9853.51%. This contributed to the annual value of 0.46 for FY2024, which is 8943.08% up from last year.
  • Per Precision Biosciences' latest filing, its Asset Utilization Ratio stood at 0.01 for Q3 2025, which was down 9853.51% from 0.01 recorded in Q2 2025.
  • In the past 5 years, Precision Biosciences' Asset Utilization Ratio registered a high of 0.53 during Q4 2021, and its lowest value of 0.01 during Q3 2025.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.3 (2023), whereas its average is 0.3.
  • As far as peak fluctuations go, Precision Biosciences' Asset Utilization Ratio surged by 32134.51% in 2021, and later plummeted by 9853.51% in 2025.
  • Over the past 5 years, Precision Biosciences' Asset Utilization Ratio (Quarter) stood at 0.53 in 2021, then plummeted by 81.31% to 0.1 in 2022, then surged by 205.43% to 0.3 in 2023, then soared by 57.76% to 0.47 in 2024, then plummeted by 98.55% to 0.01 in 2025.
  • Its Asset Utilization Ratio stands at 0.01 for Q3 2025, versus 0.01 for Q2 2025 and 0.39 for Q1 2025.